Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript

2025-03-14 10:36:24 ET

Cellectis S.A. (CLLS)

Q4 2024 Earnings Conference Call

March 14, 2025, 08:00 AM ET

Company Participants

Arthur Stril - CFO and Chief Business Officer

Andre Choulika - CEO

Adrian Kilcoyne - CMO

Conference Call Participants

Gena Wang - Barclays

Jack Allen - Baird

Sebastiaan van der Schoot - Kempen

Silvan Tuerkcan - Citizens

Jack Allen - Baird

Hangfei Fu - Jefferies

Presentation

Operator

Good day, everyone, and welcome to today's Cellectis Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note, today's conference is being recorded. [Operator Instructions]

It is now my pleasure to turn the conference over to Arthur Stril. Please go ahead.

Arthur Stril

Good morning, and welcome, everyone, to Cellectis fourth quarter and full year 2024 business update and financial results conference call. Joining me on the call today are Dr. Andre Choulika, our Chief Executive Officer; and Dr. Adrian Kilcoyne, our Chief Medical Officer.

Yesterday evening, Cellectis issued a 6-K and press release reporting our financial statements for the 12-months period ended December 31, 2024, and a business updates. The report and press release are available on our website at cellectis.com....

Read the full article on Seeking Alpha

For further details see: